Drugs and Cardiovascular Risk in Inflammatory Arthritis: Another Case of Glucocorticoid-Bashing?

Annals of the Rheumatic Diseases - United Kingdom
doi 10.1136/annrheumdis-2015-207412
Full Text
Abstract

Available in full text

Date
Authors
Publisher

BMJ

Related search

Managing Cardiovascular Risk in Patients With Inflammatory Arthritis: Practical Considerations

Therapeutic Advances in Musculoskeletal Disease
RheumatologyOrthopedicsSports Medicine
2016English

Anti-Inflammatory Drugs for Rheumatoid Arthritis

BMJ
1976English

Cardiovascular Risk in Patients With Psoriatic Arthritis

Terapevticheskii Arkhiv
Internal MedicineEndocrinologyMetabolismDiabetes
2016English

Inflammatory Markers, Endothelial Function and Cardiovascular Risk

Jornal Vascular Brasileiro
Cardiovascular MedicineCardiology
2014English

Modification of Cardiovascular Risk: Lifestyle v. Drugs

Proceedings of the Nutrition Society
MedicineNutritionDietetics
2000English

Risks Find the Owner: Another Example of Cardiovascular Risk Screening

Cardiologia Croatica
Cardiovascular MedicineCardiology
2016English

Lipid Lowering Drugs and Inflammatory Changes: An Impact on Cardiovascular Outcomes?

Annals of Medicine
Medicine
2018English

Review: The Choice and Cardiovascular Safety of Particular Nonsteroidal Anti-Inflammatory Drugs

Seminars in Cardiovascular Medicine
2018English

Gamma-Glutamyl Transferase: Another Biomarker for Metabolic Syndrome and Cardiovascular Risk

Arteriosclerosis, Thrombosis, and Vascular Biology
Cardiovascular MedicineCardiology
2007English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy